Betamethasone Sodium Phosphate And Betamethasone Acetate Injection, Suspension
Product Images NDC 0517-0799

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Betamethasone Sodium Phosphate And Betamethasone Acetate (NDC 0517-0799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Betamethasone Premier 1)

FDA Label Image

Structural Formula (Betamethasone Premier 2)

FDA Label Image

Premier Logo (Betamethasone Premier 3)

FDA Label Image

Container Label Premier (Betamethasone Premier 4)

This is a description of an injectable drug with the NDC number 0517-0799-01. The drug is a Betamethasone Acetate Injectable Suspension, used for intralesional, intrabursal, and intradermal treatment. It must not be used intravenously. The drug comes in a 5 mL multiple dose vial and is manufactured by American R PremierProRx.*

FDA Label Image

Carton Labeling Premier (Betamethasone Premier 5)

FDA Label Image

Beta Premier Serialization Label (Betamethasone Premier 6)

Product lot code is "TEST" with an expiration date of November 2020. The GTIN code is 00305170799014, and there is a serial number of "0".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.